Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway

BACKGROUND: Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, is reported to exert anti-tumor effects by upregulating the expression of the natural killer group 2D (NKG2D) ligands on tumor cells; however, the mechanisms vary in different tumor types, and the effect and mechanism of action...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shi, Pengfei, Yin, Tao, Zhou, Feng, Cui, Pengfei, Gou, Shanmiao, Wang, Chunyou
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4076062/
https://ncbi.nlm.nih.gov/pubmed/24885711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-370
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak